Myriad Reports 20 Percent Q1 Revenue Growth, Rising Demand for Colorectal ... GenomeWeb Daily News ... or bipolar disorder; a test to gauge the risk of kidney transplant rejection; a test to help doctors differentiate patients who have mild cognitive impairment from those who have Alzheimer's disease; and a blood-based colon cancer diagnosis test. ... |
